title: [Golimumab (Simponi)--first subcutaneous anti-TNF with once-monthly application].
authors.affiliation: Klinika za reumatske bolesti i rehabilitaciju, Referentni centar MZSS RH za reumatoidni artritis, Kispatićeva 12, 10000 Zagreb. dnaglic@kbc-zagreb.hr
authors.forename: Durdica
authors.initials: D
authors.lastname: Babić-Naglić
authors.forename: Branimir
authors.initials: B
authors.lastname: Anić
authors.forename: Srdan
authors.initials: S
authors.lastname: Novak
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001168:Arthritis / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab